CARDIO-ONCOLOGY – A NEW SUBSPECIALTY: Cardiovascular Toxicity Secondary To Onco-Hematologic Treatments
CARDIO-ONCOLOGY – A NEW SUBSPECIALTY: Cardiovascular Toxicity Secondary To Onco-Hematologic Treatments. Most patients who receive onco-hematologic treatment have a potential risk of cardiotoxicity. Cancer patients can present a variety of cardiovascular problems, the most frequent: ischemia, arrhythmias, valvular heart disease,